BiotechTube
Concept Life Sciences

Concept Life Sciences

Manchester, United Kingdom· Est.
conceptlifesciences.com
Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Total funding raised: $10M

Overview

Concept Life Sciences is a privately-held, revenue-generating CRO founded in 2014 and headquartered in Manchester, UK. It operates as a full-service partner for biopharma clients, offering integrated programs and standalone services across biology, chemistry, and ADME/DMPK to accelerate drug discovery. The company has a proven track record, having contributed to advancing 5 drugs to market, 28 candidates to the clinic, and 44 to the pre-clinical stage for its clients. Its business model is centered on providing scientific expertise and strategic execution to reduce development timelines for partner organizations.

Drug DeliveryDiagnostics

Technology Platform

Integrated CRO service platform combining translational biology, end-to-end chemistry (discovery to GMP), and ADME/DMPK expertise to support drug discovery across small molecules, biologics, and Cell & Gene Therapies.

Funding History

2
Total raised:$10M
Debt$10M
Series AUndisclosed

Opportunities

Growth is driven by the expanding biopharma outsourcing trend, particularly among virtual and small biotechs.
The increasing complexity of drug modalities like Cell & Gene Therapies and biologics creates demand for the integrated, specialized expertise Concept offers.
Their proven track record in accelerating client programs is a key asset for business development.

Risk Factors

Faces intense competition from large global CROs and niche specialists.
Revenue is susceptible to downturns in biotech funding, which can reduce client R&D spending.
Operational performance and reputation are critical; any significant project failures or data issues could harm future client acquisition.

Competitive Landscape

Concept Life Sciences competes in the fragmented global CRO market. It differentiates itself from large, sometimes siloed, global CROs by emphasizing deep scientific integration across biology and chemistry and a strategic partnership model. It also competes with smaller, specialty CROs by offering a broader, 'Concept to Clinic' suite of services.

More companies in United Kingdom →